JERRY L MALIS
CIK 1189783 · EVP & Chief Scientific Officer · last filed 2013-10-18
JERRY L MALIS is an EVP & Chief Scientific Officer who has filed 24 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing shows the insider sold $45.7K of SURG on Oct 18, 2013. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.3K
1
24
-$3.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SURG | EVP & Chief Scientific Officer | 10,884 | $0.21 | $2.3K | -$3.20M | 24 | 2013-10-18 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-10-18 | SURG | Sell (S) | −10,000 | -$45.7K | EDGAR |
| 2013-10-16 | SURG | Sell (S) | −40,000 | -$182.1K | EDGAR |
| 2013-10-10 | SURG | Sell (S) | −50,605 | -$232.9K | EDGAR |
| 2013-10-08 | SURG | Sell (S) | −49,395 | -$222.2K | EDGAR |
| 2012-12-20 | SURG | Grant (A) | +7,395 | $0 | EDGAR |
| 2012-02-21 | SURG | Sell (S) | −1,500 | -$10.5K | EDGAR |
| 2012-02-10 | SURG | Sell (S) | −2,000 | -$14.0K | EDGAR |
| 2012-02-06 | SURG | Sell (S) | −440 | -$3.1K | EDGAR |
| 2012-01-04 | SURG | Sell (S) | −20,000 | -$149.2K | EDGAR |
| 2012-01-03 | SURG | Sell (S) | −10,000 | -$73.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.